HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R.

Diabetes Research and Clinical Practice

Volumn 96, Issue 3, 2012, Pages 392-399

  Soulimane, Soraya ^a,b   Simon, Dominique ^a,c   Shaw, Jonathan ^d   Witte, Daniel ^e   Zimmet, Paul ^d   Vol, Sylviane ^f   Borch Johnsen, Knut ^g   Magliano, Dianna ^d   Vistisen, Dorte ^e   Balkau, Beverley ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e STENO DIABETES CENTER   (Denmark)

^f Inst Inter Rég Pour la S   (France)

^g UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Diabetes; Epidemiology; Fasting plasma glucose; HbA1c

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; AUSTRALIAN; COHORT ANALYSIS; CONFIDENCE INTERVAL; DANISH; DIABETES MELLITUS; DIET RESTRICTION; ETHNIC GROUP; FEMALE; FRENCH LANGUAGE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREDICTIVE VALUE; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STANDARDIZATION;

ADULT; AGED; AUSTRALIA; BIOLOGICAL MARKERS; BLOOD GLUCOSE; COHORT STUDIES; DENMARK; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FRANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84862226057     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.06.003     Document Type: Article

References (28)

1. Narayan K.M., Boyle J.P., Geiss L.S., Saaddine J.B., Thompson T.J. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006, 29:2114-2116.
2. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
3. Droumaguet C., Balkau B., Simon D., Caces E., Tichet J., Charles M.A., et al. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006, 29:1619-1625.
4. Abdul-Ghani M.A., Lyssenko V., Tuomi T., DeFronzo R.A., Groop L. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 2009, 32:281-286.
5. American Diabetes Association Screening for type 2 diabetes. Diabetes Care 2004, 27(Suppl. 1):S11-S14.
6. Kim C., Bullard K.M., Herman W.H., Beckles G.L. Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care 2010, 33:780-785.
7. Borch-Johnsen K., Colagiuri S. Diagnosing diabetes-time for a change?. Diabetologia 2009, 52:2247-2250.
8. Consensus Committee Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007, 30:2399-2400.
9. Hanas R., John G. 2010 consensus statement on the worldwide standardization of the hemoglobin A(1c) measurement. Diabetes Res Clin Pract 2010, 90:228-230.
10. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl. 1):S62-S69.
11. International Expert Committee International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
12. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl. 1):S5-S20.
13. Borch-Johnsen K., Colagiuri S., Balkau B., Glumer C., Carstensen B., Ramachandran A., et al. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 2004, 47:1396-1402.
14. Dekker J.M., Balkau B. Counterpoint: impaired fasting glucose: the case against the new American Diabetes Association guidelines. Diabetes Care 2006, 29:1173-1175.
15. Sato K.K., Hayashi T., Harita N., Yoneda T., Nakamura Y., Endo G., et al. Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare Study. Diabetes Care 2009, 32:644-646.
16. Cederberg H., Saukkonen T., Laakso M., Jokelainen J., Härkönen P., Timonen M., et al. Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study. Diabetes Care 2010, 33:2077-2083.
17. Glumer C., Jorgensen T., Borch-Johnsen K. Inter99 study, prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 2003, 26:2335-2340.
18. Dunstan D.W., Zimmet P.Z., Welborn T.A., Cameron A.J., Shaw J., de Courten M., et al. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)-methods and response rates. Diabetes Res Clin Pract 2002, 57:119-129.
19. Magliano D.J., Barr E.L., Zimmet P.Z., Cameron A.J., Dunstan D.W., Colagiuri S., et al. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2008, 31:267-272.
20. Ulm K. A statistical method for assessing a threshold in epidemiological studies. Stat Med 1991, 10:341-349.
21. Edelman D., Olsen M.K., Dudley T.K., Harris A.C., Oddone E.Z. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004, 19:1175-1180.
22. Mostafa S.A., Khunti K., Srinivasan B.T., Webb D., Gray L.J., Davies M.J. The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort. Diabetes Res Clin Pract 2010, 90:100-108.
23. Zhang X., Gregg E.W., Williamson D.F., Barker L.E., Thomas W., Bullard K.M., et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care 2010, 33:1665-1673.
24. Nakagami T., Tajima N., Oizumi T., Karasawa S., Wada K., Kameda W., et al. Hemoglobin A1c in predicting progression to diabetes. Diabetes Res Clin Pract 2010, 87:126-131.
25. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
26. Inoue K., Matsumoto M., Akimoto K. Fasting plasma glucose and HbA1c as risk factors for type 2 diabetes. Diabet Med 2008, 25:1157-1163.
27. Saaddine J.B., Fagot-Campagna A., Rolka D., Narayan K.M., Geiss L., Eberhardt M., et al. Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care 2002, 25:1326-1330.
28. Soulimane S, Simon D, Shaw JE, Zimmet PZ, Vol S, Vistisen D, et al. Comparing incident diabetes as defined by fasting plasma glucose or by HbA1c. The AusDiab, Inter99 and D.E.S.I.R. studies. Diabet Med, in press.